Business Wire

Masimo Announces FDA Clearance for Neonatal RD SET ® Pulse Oximetry Sensors with Improved Accuracy Specifications

Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...
Nasdaq

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
News Medical

Study shows feasibility of using Masimo SET pulse oximetry for CCHD screening

Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on ...
FierceBiotech

Masimo reels in FDA nod for pulse oximetry smartwatch amid Apple Watch patent spats

The FDA clearance allows the W1 wearable to be sold for both over-the-counter and prescription use—making it the first SpO2-tracking smartwatch to carry both indications in the U.S., per Masimo.
Mena FN

Masimo SET® Pulse Oximetry Performed Accurately On Hospitalized Newborns Of All Skin Tones In Largest-Ever Prospective R...

These promising results-from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile patient population-add to previously published evidence of its strong ...